PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

GENENTECH, INC.

CA · US

Leading biotechnology co. focused on medicines for serious or life threatening conditions

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$11,350,000

Connections

13

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$20.0M
MMMMedicare/Medicaid
$17.3M
PHAPharmacy
$17.0M
BUDBudget/Appropriations
$16.9M
CPTCopyright/Patent/Trademark
$16.5M
TRDTrade
$16.2M
TAXTaxation/Internal Revenue Code
$16.1M
MANManufacturing
$15.3M
IMMImmigration
$15.3M
MEDMedical/Disease Research
$15.3M

Lobbying Firms Retained

GENENTECH, INC.$15.3M
TODD STRATEGY GROUP$900K
TARPLIN, DOWNS & YOUNG, LLC$840K
OGR$820K
MARSHALL & POPP, LLC$780K
Harbinger Strategies$770K
TIBER CREEK HEALTH STRATEGIES, INC.$720K
AKIN GUMP STRAUSS HAUER & FELD$700K
CORNERSTONE GOVERNMENT AFFAIRS, INC.$700K
King & Spalding LLP$400K
YC CONSULTING, LLC$130K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byMARSHALL & POPP, LLCHired MARSHALL & POPP, LLC to lobby on PBM Reform ActSource
Employed byTIBER CREEK HEALTH STRATEGIES, INC.Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on PBM Reform ActSource
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000Source
Employed byOGRHired OGR to lobby on PBM Reform ActSource
Employed byTARPLIN, DOWNS & YOUNG, LLCHired TARPLIN, DOWNS & YOUNG, LLC to lobby on PharmaceuticalsSource
Lobbied forMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $3,100,000Source
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing ModelSource
Employed byAKIN GUMP STRAUSS HAUER & FELDHired AKIN GUMP STRAUSS HAUER & FELD to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byHarbinger StrategiesHired HARBINGER STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byCORNERSTONE GOVERNMENT AFFAIRS, INC.Hired CORNERSTONE GOVERNMENT AFFAIRS, INC. to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byTODD STRATEGY GROUPHired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byKing & Spalding LLPHired KING & SPALDING LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byYC CONSULTING, LLCHired YC CONSULTING, LLC to lobby (4th Quarter (Oct 1 - Dec 31) 2025)Source